Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases (2019)
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: ESTRESSE OXIDATIVO, DOENÇAS CARDIOVASCULARES, DOENÇAS METABÓLICAS
ABNT
COSTA, Rafael Menezes da et al. Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases. Frontiers in Pharmacology, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.3389/fphar.2019.00382. Acesso em: 07 out. 2024.APA
Costa, R. M. da, Rodrigues, D., Pereira, C. A., Silva, J. F. da, Alves, J. V., Lobato, N. S., & Tostes, R. de C. A. (2019). Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases. Frontiers in Pharmacology, 10. doi:10.3389/fphar.2019.00382NLM
Costa RM da, Rodrigues D, Pereira CA, Silva JF da, Alves JV, Lobato NS, Tostes R de CA. Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases [Internet]. Frontiers in Pharmacology. 2019 ; 10[citado 2024 out. 07 ] Available from: https://doi.org/10.3389/fphar.2019.00382Vancouver
Costa RM da, Rodrigues D, Pereira CA, Silva JF da, Alves JV, Lobato NS, Tostes R de CA. Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases [Internet]. Frontiers in Pharmacology. 2019 ; 10[citado 2024 out. 07 ] Available from: https://doi.org/10.3389/fphar.2019.00382